EMPOWER Study: Using a Chatbot for Breast Cancer Screening Follow-up

This study, called EMPOWER, is looking at how a digital tool called a chatbot can help women with their breast cancer screening. The chatbot will be used after you have a mammogram (an X-ray of the breast) to answer questions and provide information. We want to see if using this chatbot helps women stick to their recommended screening schedule. You can join if you are an adult woman (18 or older), speak English or Spanish, and are having a routine mammogram at the University of Utah. The study will compare women who receive usual care to those who also use the chatbot. We are hoping to enroll 2700 participants.

Study design
This study is interventional and will involve 2700 participants. You will be randomly assigned to either receive usual care or usual care plus the chatbot.
What's involved
You will complete a baseline survey at the start of the study. The chatbot communication will be initiated through your preferred contact method (text or email) and can be completed via phone or website.
Compensation
Not stated in the trial record.
Follow-up
Your screening adherence will be measured for up to 24 months after you start the study intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07029490

Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study

Recruiting
NAAges 18+InterventionalHealth services
University of Utah
~2,700 participants
Updated 2025-11-21 on ClinicalTrials.gov
What's tested:Chatbot

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Screening Adherence
Measured over up to 24 months from initiation of study intervention
Breast Cancer
1 sites across 1 states
Utah1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adult (equal to or above 18 years old)
English or Spanish speaking
Visit a mammography program for routine screening.

Exclusion

Patients who are currently in treatment for breast cancer
Patients who are not of 18 years of age.
Patients who don't speak English or Spanish
Men
Cognitive limitations that impede informed consent
  • Screening Adherenceup to 24 months from initiation of study intervention

    This outcome measure will test the addition of virtual navigation to usual processes of care to increase screening adherence for underserved women undergoing mobile mammography who have an abnormal breast cancer screening exam. Screening adherence will be measured as a two-point survey item (Yes/No). This outcome measure will report the proportion of participants who self-reported screening adherence.